Dynavax Technologies
DVAX
#5492
Rank
ยฃ0.96 B
Marketcap
ยฃ8.21
Share price
-0.09%
Change (1 day)
-19.11%
Change (1 year)

Dynavax Technologies (DVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ0.30 Billion

According to Dynavax Technologies 's latest financial reports the company's total liabilities are ยฃ0.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dynavax Technologies - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.31 B5.43%
2023-12-31ยฃ0.29 B-12.03%
2022-12-31ยฃ0.33 B-44.7%
2021-12-31ยฃ0.60 B180.02%
2020-12-31ยฃ0.21 B4.66%
2019-12-31ยฃ0.20 B77.32%
2018-12-31ยฃ0.11 B718.18%
2017-12-31ยฃ14.23 M-14.24%
2016-12-31ยฃ16.59 M-16.78%
2015-12-31ยฃ19.94 M-17.88%
2014-12-31ยฃ24.28 M118.56%
2013-12-31ยฃ11.11 M-27.95%
2012-12-31ยฃ15.42 M-29.96%
2011-12-31ยฃ22.01 M5.76%
2010-12-31ยฃ20.81 M-23.6%
2009-12-31ยฃ27.24 M-46.37%
2008-12-31ยฃ50.8 M24.13%
2007-12-31ยฃ40.93 M236.63%
2006-12-31ยฃ12.15 M265.95%
2005-12-31ยฃ3.32 M-53.67%
2004-12-31ยฃ7.17 M-85.55%
2003-12-31ยฃ49.63 M-9.41%
2002-12-31ยฃ54.78 M60.37%
2001-12-31ยฃ34.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
ยฃ0.38 B 24.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ8.23 B 2,567.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ58.15 B 18,727.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ27.77 B 8,891.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ51.29 B 16,507.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
ยฃ45.90 B 14,761.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ86.61 B 27,941.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ24.42 B 7,806.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
ยฃ60.31 B 19,426.73%๐Ÿ‡บ๐Ÿ‡ธ USA